American Healthcare REIT, Inc. (AHR) — Financial statements
Income statement, balance sheet, and cash flow for American Healthcare REIT, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2,260↑9.1% | 2,071↑11.4% | 1,859↑14.9% | 1,618↑28.0% | 1,264 | |
| Cost of Revenue | 2,220↑34.3% | 1,654↑10.1% | 1,502↑17.2% | 1,282↑18.4% | 1,082 | |
| Gross Profit | 40↓90.5% | 417↑16.8% | 357↑6.2% | 336↑84.6% | 182 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 101↓4.0% | 105↑1.8% | 103↑138.7% | 43 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00↓100.0% | 101↓4.0% | 105↑1.8% | 103↑138.7% | 43 | |
| Other Expenses | -128↓171.5% | 179↑2.3% | 175↑23.1% | 142 | 0.00 | |
| Operating Expenses | -128↓145.8% | 280↓0.0% | 280↑14.2% | 245↑468.0% | 43 | |
| Total Costs & Expenses | 2,092↑8.2% | 1,934↑8.5% | 1,782↑16.7% | 1,527↑35.7% | 1,125 | |
| Operating Results | ||||||
| Operating Income | 168↑22.7% | 137↑78.3% | 77↓15.3% | 91↓34.7% | 139 | |
| Depreciation & Amortization | 188↓15.4% | 222↓6.6% | 237↑18.3% | 201↑30.4% | 154 | |
| EBITDA | 322↑2.1% | 315↓2.7% | 324↑38.7% | 234↑46.6% | 159 | |
| EBIT | 134↑43.2% | 94↑7.9% | 87↑162.3% | 33↑490.2% | 6 | |
| Interest & Other Income | ||||||
| Net Interest Income | -86↑32.8% | -128↑21.7% | -163↓54.0% | -106↓30.9% | -81 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 86↓32.8% | 128↓21.7% | 163↑54.0% | 106↑30.9% | 81 | |
| Non-Operating Income | 33↓22.2% | 43↑519.0% | -10↓117.8% | 57↓56.9% | 133 | |
| Other Income / Expenses | -119↑30.2% | -171↓11.6% | -153↑6.4% | -163↑14.5% | -191 | |
| Income Before Tax | 49↑243.6% | -34↑55.5% | -76↓4.7% | -73↓39.2% | -52 | |
| Income Tax Expense | -22↓1394.3% | 2↑158.4% | 0.66↑13.1% | 0.59↓38.7% | 0.96 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 71↑298.9% | -36↑53.7% | -77↓4.8% | -73↓37.8% | -53 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 70↑284.6% | -38↑47.1% | -71↑12.1% | -81↓70.1% | -48 | |
| Bottom-Line Net Income | 70↑284.6% | -38↑47.1% | -71↑12.1% | -81↓70.1% | -48 | |
| EPS (Basic) | 0.42↑244.8% | -0.29↑73.1% | -1.08↑12.2% | -1.23↓70.8% | -0.72 | |
| EPS (Diluted) | 0.42↑244.8% | -0.29↑73.1% | -1.08↑12.2% | -1.23↓70.8% | -0.72 | |
| Weighted Average Shares | 166↑27.1% | 131↑97.8% | 66↓0.2% | 66↑0.0% | 66 | |
| Weighted Average Diluted Shares | 167↑27.7% | 131↑97.8% | 66↓0.2% | 66↑0.0% | 66 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.